🔎 Trials Near Me

Domov › Mantle cell lymfóm › New York

Klinické štúdie Mantle cell lymfóm v štáte New York

16 štúdií pre Mantle cell lymfóm hľadá účastníkov v zariadeniach v štáte New York.

Mestá v štáte New York

Oficiálny text štúdie (anglicky)

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

  • Roswell Park Cancer Institute, Buffalo
  • Hematology Oncology Associates of CNY at Camillus, Camillus
  • Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse
  • a 5 ďalších
Prebieha náborFáza 3
Vek 60 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05976763

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

  • Research Site, New York
  • Research Site, New York
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06542250

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

  • Memorial Sloan Kettering Cancer Center Mskcc, New York
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06742996

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Columbia University Medical Center, New York
  • Weill Cornell Medical College Newyork Presbyterian Hospital, New York
  • a 1 ďalších
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT05006716

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • New York University (NYU) Clinical Cancer Center, New York
  • Weill Cornell Medicine, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07101328

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

  • Research Site, New York
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06564038

A Study of ARC-02 in B-cell NHL

  • NYU Langone, New York
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT07691606

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • New York Medical College, Valhalla
Prebieha náborFáza 1/2
Vek 13 až 90 · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT06533579

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

  • Roswell Park Cancer Institute, Buffalo
  • Memorial Sloan Kettering Cancer Center - Bergen, New York
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 7. 2026 · NCT07121946

DALY II USA/ MB-CART2019.1 for DLBCL

  • Memorial Sloan Kettering Cancer Center, New York
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 7. 2026 · NCT04792489

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

  • New York Medical Center, Valhalla
Prebieha náborFáza 1/2
Vek 12 až 70 · Všetky pohlavia · Aktualizované 15. 4. 2026 · NCT04491370

BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma

  • Memorial Sloan Kettering Cancer Center, New York
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 2. 2026 · NCT06854003

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Weill Cornell, New York
  • Montefiore Medical Center, The Bronx
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 2. 2026 · NCT05544019

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

  • Optum Medical Care PC, Westbury
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 12. 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Buffalo
  • Massive Bio SYNERGY-AI site, Hempstead
  • Massive Bio SYNERGY-AI site, Manhasset
  • a 2 ďalších
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors

  • Northwell (Northshore University/Long Island Jewish Hospitals), New Hyde Park
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2025 · NCT05643235

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.